AMONDYS

Serial Number 88559700
Registration 6548209
700

Registration Progress

Application Filed
Aug 1, 2019
Under Examination
Dec 31, 2019
Approved for Publication
Nov 5, 2019
Published for Opposition
Nov 5, 2019
Registered
Nov 2, 2021

Trademark Image

AMONDYS

Basic Information

Serial Number
88559700
Registration Number
6548209
Filing Date
August 1, 2019
Registration Date
November 2, 2021
Published for Opposition
November 5, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 2, 2021
Registration
Registered
Classes
005

Rights Holder

Sarepta Therapeutics, Inc.

03
Address
215 First Street
Cambridge, MA 02142

Ownership History

Sarepta Therapeutics, Inc.

Original Applicant
03
Cambridge, MA

Sarepta Therapeutics, Inc.

Owner at Publication
03
Cambridge, MA

Sarepta Therapeutics, Inc.

Original Registrant
03
Cambridge, MA

Legal Representation

Attorney
Maury M. Tepper, III

USPTO Deadlines

Next Deadline
821 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-11-02)
Due Date
November 02, 2027
Grace Period Ends
May 02, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

27 events
Date Code Type Description Documents
Nov 2, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Sep 29, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Sep 28, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Sep 22, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Sep 13, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Sep 2, 2021 IUAF S USE AMENDMENT FILED Loading...
Sep 2, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jun 16, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 14, 2021 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jun 14, 2021 EXT3 S SOU EXTENSION 3 FILED Loading...
Jun 14, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 15, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 10, 2020 EX2G S SOU EXTENSION 2 GRANTED Loading...
Dec 10, 2020 EXT2 S SOU EXTENSION 2 FILED Loading...
Dec 10, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 20, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 18, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 18, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 18, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 31, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 5, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 5, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 16, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 3, 2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 30, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 19, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 5, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders
First Use Anywhere: Feb 25, 2021
First Use in Commerce: Feb 25, 2021

Classification

International Classes
005